Medicare Enrolled
Dr. Mohammed Pathan, MD
Neurology · Columbus, GA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Pathan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Pathan?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Pathan
Dr. Mohammed Pathan is a neurology specialist in Columbus, GA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Pathan performed 48,030 Medicare services across 1,795 unique beneficiaries.
Between the years covered by Open Payments, Dr. Pathan received a total of $15,506 from 70 pharmaceutical and/or device companies across 716 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Pathan is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 1% volume in GA
$15,506 industry payments
Medicare Practice Summary
Medicare Utilization ↗48,030
Medicare services
Top 1% in GA for neurology
1,795
Unique beneficiaries
$10
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~2,402 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
45,340 | $5 | $7 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,395 | $84 | $250 |
| New patient office visit, complex (60-74 min) | 253 | $148 | $495 |
| Bilateral facial and neck nerve muscle paralysis injection Injection of a chemical agent to paralyze muscles in the face and neck on both sides. |
207 | $116 | $650 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
183 | $130 | $504 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
114 | $63 | $262 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
94 | $91 | $259 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
89 | $57 | $155 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
54 | $113 | $395 |
| Trigger point injection, 3 or more muscles Injection of medication into three or more specific muscle trigger points to relieve pain. |
45 | $23 | $125 |
| Injection of anesthetic or steroid into upper neck and back of head nerve An injection of an anesthetic agent and/or steroid into a nerve located in the upper neck and back of the head. |
42 | $55 | $349 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
41 | $261 | $897 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
33 | $314 | $1,350 |
| EEG monitoring for coma or sleep This procedure measures brain wave activity to monitor patients who are in a coma or asleep. |
31 | $42 | $610 |
| Sleep study in sleep lab (age 6+) An overnight test conducted in a sleep laboratory to monitor sleep patterns and bodily functions in patients aged 6 years or older. |
21 | $78 | $595 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
20 | $146 | $546 |
| Nerve conduction studies, 13 or more A diagnostic test that measures how well nerves send electrical signals. This code applies when 13 or more individual nerve studies are performed. |
20 | $205 | $613 |
| Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | 19 | $55 | $163 |
| Sleep study with heart rate and breathing monitoring A sleep study that monitors heart rate, breathing, airflow, and physical effort during sleep. |
18 | $30 | $250 |
| Nerve conduction studies, 7-8 tests A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles. |
11 | $88 | $342 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$15,506
Total received (2018-2024)
Avg $2,215/year across 7 years
Top 19% in GA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
70
Companies
716
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,495 (99.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$11 (0.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,991
2023
$2,589
2022
$2,179
2021
$1,653
2020
$873
2019
$4,524
2018
$1,697
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$351
UCB, Inc.
$275
HARMONY BIOSCIENCES LLC
$139
Inspire Medical Systems, Inc.
$111
Neurelis, Inc.
$101
Lundbeck LLC
$100
JAZZ PHARMACEUTICALS INC.
$80
Neurocrine Biosciences, Inc.
$78
PFIZER INC.
$76
SCILEX PHARMACEUTICALS INC.
$71
Novartis Pharmaceuticals Corporation
$68
ARGENX US, INC.
$68
TG Therapeutics, Inc.
$60
CATALYST PHARMACEUTICALS, INC.
$59
Eisai Inc.
$47
MDD US Operations, LLC
$45
Alexion Pharmaceuticals, Inc.
$44
Harmony Biosciences Llc
$35
Kyowa Kirin, Inc.
$35
Takeda Pharmaceuticals U.S.A., Inc.
$24
Sumitomo Pharma America, Inc.
$23
Alnylam Pharmaceuticals Inc.
$23
Kedrion Biopharma, Inc.
$22
Biogen, Inc.
$20
ACADIA Pharmaceuticals Inc
$19
Genentech USA, Inc.
$19
Top 3 companies account for 38.4% of 2024 payments
All-time payments by company (2018-2024) ›
LivaNova USA, Inc.
$1,910
ABBVIE INC.
$1,257
Medtronic Vascular, Inc.
$865
Biogen, Inc.
$813
JAZZ PHARMACEUTICALS INC.
$638
GENZYME CORPORATION
$624
Novartis Pharmaceuticals Corporation
$608
Teva Pharmaceuticals USA, Inc.
$569
UCB, Inc.
$533
Sunovion Pharmaceuticals Inc.
$465
Alexion Pharmaceuticals, Inc.
$456
Genentech USA, Inc.
$456
Supernus Pharmaceuticals, Inc.
$404
Harmony Biosciences LLC
$389
Amgen Inc.
$330
Eisai Inc.
$304
HARMONY BIOSCIENCES LLC
$272
Greenwich Biosciences, Inc.
$270
Janssen Pharmaceuticals, Inc
$263
Lilly USA, LLC
$257
Neurelis, Inc.
$231
AbbVie Inc.
$225
SK Life Science, Inc.
$220
Lundbeck LLC
$188
Adamas Pharmaceuticals, Inc.
$179
ACADIA Pharmaceuticals Inc
$165
PFIZER INC.
$143
ARGENX US, INC.
$137
Celgene Corporation
$130
EISAI INC.
$127
Travere Therapeutics, Inc.
$124
Allergan, Inc.
$116
Neurocrine Biosciences, Inc.
$114
Inspire Medical Systems, Inc.
$111
Avanir Pharmaceuticals, Inc.
$103
Biohaven Pharmaceutical Holding Company Ltd.
$98
Merz Pharmaceuticals, LLC
$85
Allergan Inc.
$83
Amneal Pharmaceuticals LLC
$81
Kyowa Kirin, Inc.
$78
CATALYST PHARMACEUTICALS, INC.
$75
EMD Serono, Inc.
$74
SCILEX PHARMACEUTICALS INC.
$71
US WorldMeds, LLC
$68
Catalyst Pharmaceuticals, Inc.
$67
Biohaven Pharmaceuticals, Inc.
$64
TG Therapeutics, Inc.
$60
Sumitomo Pharma America, Inc.
$51
MDD US Operations, LLC
$45
Corium, LLC
$42
Upsher-Smith Laboratories LLC
$35
Harmony Biosciences Llc
$35
CSL Behring
$33
Axsome Therapeutics, Inc.
$29
Otsuka America Pharmaceutical, Inc.
$28
Zyla Life Sciences
$28
Impax Laboratories, Inc.
$27
TG THERAPEUTICS, INC.
$25
Genentech, Inc.
$25
Takeda Pharmaceuticals U.S.A., Inc.
$24
Alnylam Pharmaceuticals Inc.
$23
AQUESTIVE THERAPEUTICS, INC.
$22
Kedrion Biopharma, Inc.
$22
Banner Life Sciences, LLC
$21
Mitsubishi Tanabe Pharma America, Inc.
$20
Mallinckrodt LLC
$20
Zogenix Inc.
$14
IMPEL PHARMACEUTICALS INC.
$14
Boston Scientific Corporation
$13
Acorda Therapeutics, Inc
$11
Top 3 companies account for 26.0% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AIMOVIG · AJOVY · AMVUTTRA · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Activase · Adlarity · Aimovig · Albuked · Austedo XR · BAFIERTAM · BOTOX · BOTOX THERAPEUTIC · BRIUMVI · Briviact · COMIRNATY · COPAXONE · DUOPA · EMGALITY · EPIDIOLEX · Epidiolex · FIRDAPSE · FORTEO · FYCOMPA · Fintepla · Fycompa · GENERAL PAIN MANAGEMENT · GILENYA · GOCOVRI · Gocovri · HYQVIA · Hizentra · INBRIJA · INGREZZA · INSPIRE · KESIMPTA · KYNMOBI · LEMTRADA · Leqembi · MAYZENT · MS DISEASE STATE · Mavenclad · NEXVIAZYME · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Nourianz · Nuedexta · OCREVUS · OXTELLAR XR · Ocrevus · PLEGRIDY · Ponvory · QULIPTA · REXULTI · RYTARY · Radicava · Rebif · Rystiggo · SKYCLARYS · SOLIRIS · SPRIX · SYMPAZAN · Soliris · Sunosi · TECFIDERA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · VALTOCO · VNS - Sentiva · VNS Therapy · VNS Therapy SenTiva Model 1000 Generator · VRAYLAR · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · WAKIX · Wakix · XCOPRI · XYREM · XYWAV · Xadago · Xeomin · ZEPOSIA · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Neurologists within 10 mi
11
Per 100K population
5.4
County median income
$56,622
Nearest hospital
JACK HUGHSTON MEMORIAL HOSPITAL
4.0 mi
4.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Pathan is a mixed practice specialist, with above-average Medicare volume (top 1% in GA), with low-engagement industry engagement in the top 19% of GA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Pathan experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Pathan performed 45,340 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Pathan receive payments from pharmaceutical companies?
Yes. Dr. Pathan received a total of $15,506 from 70 companies across 716 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Pathan's costs compare to other neurologists in Columbus?
Dr. Pathan's average Medicare payment per service is $10. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Pathan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Columbus
Browse neurologists in Columbus ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in GA
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in GA
Which GA neurologists receive the most from drug and device companies.
By company
LivaNova USA, Inc. Payments to Doctors
See all physicians who received payments from LivaNova USA, Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Medtronic Vascular, Inc. Payments to Doctors
See all physicians who received payments from Medtronic Vascular, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology